Both in Pharmaceuticals
Gossamer Bio vs Verrica Pharmaceuticals
Over the past year GOSS returned −95.1% and VRCA returned −7.6%; their daily moves had a correlation of 0.03.
GOSS −95.1% VRCA −7.6%Growth of $1, one year, split-adjusted
| Metric | GOSS | VRCA |
|---|---|---|
| Price | $9.28 | $3.29 |
| Market cap | $56.8M | $56.5M |
| Today | −1.80% | +2.49% |
| 1 month | −12.9% | −23.7% |
| 6 months | −65.5% | −54.1% |
| Year to date | −96.3% | −60.4% |
| 1 year | −95.3% | −8.9% |
| Revenue growth (YoY) | −19.6% | −53.8% |
| Gross margin | 100.0% | 85.0% |
| Net margin | 182.9% | −224.4% |
| P/E (TTM) | — | — |
| Price / sales | 1.1× | 1.9× |
| Net cash | $20.9M | $9.8M |
| Dividend yield | — | — |
| Volatility (60d) | 1,265.9% | 62.8% |
| Short % of float | 24.9% | 2.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).